Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy

American Journal of Medical Genetics

Volumn 136 A, Issue 2, 2005, Pages 117-121

  Loureiro, Kirsten D ^a   Kao, Kelly K ^b   Jones, Kenneth Lyons ^b   Alvarado, Sonia ^b   Chavez, Carmen ^b   Dick, Lyn ^b   Felix, Robert ^b   Johnson, Diana ^b   Chambers, Christina D ^b,c  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Birth outcomes; Minor malformations; Retinoic acid embryopathy; Topical tretinoin

Indexed keywords

ISOTRETINOIN; RETINOIC ACID;

ADULT; ARTICLE; CLUBFOOT; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIAPHRAGM HERNIA; DISEASE ASSOCIATION; EMBRYOPATHY; ENVIRONMENTAL EXPOSURE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

ABNORMALITIES, DRUG-INDUCED; ADULT; CALIFORNIA; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; KERATOLYTIC AGENTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; PROSPECTIVE STUDIES; TRETINOIN;

EID: 22044458390     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30744     Document Type: Article

References (26)

1. Adams J, Lammer EJ. 1993. Neurobehavioral teratology of isotretinoin. Reprod Toxicol 7:175-177.
2. Buchan P, Eckhoff C, Caron D, Nau H, Shroot B, Schaefer H. 1994. Repeated topical administration of all-trans-retinoic acid and plasma levels of retinoic acids in humans. Journal of the American Academy of Dermatology 30:428-434.
3. Camera G, Pregliasco P. 1992. Ear malformation in baby born to mother using tretinoin cream. Lancet 339:687.
4. Campbell JL Jr, Smith MA, Fisher JW, Warren DA. 2004. Dose-response for retinoic acid-induced forelimb malformations and cleft palate: A comparison of computerized image analysis and visual inspection. Birth Def Res Part B Dev and Reprod Toxicol 71:289-295.
5. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. 1998. Maternal fever and birth outcome: A prospective study. Teratology. 58:251-257.
6. Chiang TC. 1980. Gas chromatographic-mass spectrometric assay for low levels of retinoic acid in human blood. J Chromatogr 182:335-340.
7. Franz TJ, Lehman PA, Franz SF. 1993. Topical use of retinoic acid gel is not teratogenic. J Invest Dermatol 100:490.
8. Hollingshead AB. 1965. Four factor index of social position. New Haven: Yale University, unpublished paper.
9. Jensen BK, McGann LA, Kachevsky V, Franz TJ. 1991. The negligible systemic availability of retinoids with multiple and excessive topical application of isotretinoin 0.05% gel (Isotrex) in patients with acne vulgaris. J Am Acad Dermatol 24:425-428.
10. Jick SS, Terris BZ, Jick H. 1993. First trimester topical tretinoin and congenital disorders. Lancet 341:1181-1182.
11. Jones KL, Johnson KA, Dick LM, Felix RJ, Kao KK, Chambers CD. 2002. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine. Teratology 65:125-130.
12. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, et al. 2000. CDC growth charts: United States: Vol. 314. Advance Data (No. PHS 2000-1250). Hyattsville, MD: National Center for Health Statistics.
13. Lammer EJ. Personal communication. 2004.
14. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, et al. 1985. Retinoic acid embryopathy. New Engl J Med 313:837-841.
15. Lipson AH, Collins F, Webster WS. 1993. Multiple congenital defects associated with maternal use of topical tretinoin. Lancet 341:1352-1353.
16. Lubchenko L. 1966. Pediatrics 37:403.
17. Martinez-Frias ML, Rodriguez Panilla E. 1999. First-trimester exposure to topical tretinoin: Its safety is not warranted. Teratology 60:5.
18. Navarre-Belhassen C. 1998. Multiple congenital malformations associated with topical tretinoin. Ann Pharmacother 32:505-506.
19. Schaefer H, Zesch A. 1975. Penetration of vitamin A acid into human skin. Acta Dermato-Venereologica (Stockh) 74:50-55.
20. Seegmiller RE, Carter MW, Ford WH, White RD. 1990. Induction of maternal toxicity in the rat by dermal application of retinoic acid and its effect on fetal outcome. Reprod Teratol 4:277-281.
21. Seegmiller RE, Ford WH, Carter MW, Mitala JJ, Powers WJ Jr. 1997. A developmental toxicity study of tretinoin administered topically and orally to pregnant Wistar rats. J Am Acad Dermatol 36:S60-S66.
22. Selcen D, Seidman S, Nigro MA. 2000. Otocerebral anomalies associated with topical tretinoin use. Brain Dev 22:218-220.
23. Shapiro L, Pastuszak A, Curto G, Koren G. 1997. Safety of first-trimester exposure to topical tretinoin: Prospective cohort study. Lancet 350: 1143-1144.
24. Sulik KK, Dehart DB, Rogers JM, Chernoff N. 1995. Teratogenic potential of low doses of all-trans retinoic acid in presomite mouse embyos. Teratology 51:398-403.
25. Whillhite CC, Sharma RP, Allen PV, Berry DL. 1990. Percutaneous retinoid absorption and embryotoxicity. J Investig Dermatol 95:523-529.
26. Worobec SM, Wong FA, Tolman EL, Abrams LS, Parker GR, Thorne EG. 1991. Percutaneous absorption of 3H-tretinoin in normal volunteers (abstract). J Invest Dermatol 96:574A.